Transformation of the Pharmaceutical Industry Post-Pandemic

The reason for speeding up pharmacovigilance was well highlighted during the pandemic, that was propelled by vaccine research and delivery

Greater adoption of digital technologies for drug development and clinical trials

 the focus has evidently shifted towards imparting richer in-hand experience in the industry. 

Heading 2

Increased investment in supply chain resilience

The pharmaceuticals industry is also following this path to advance its operations, deliveries and research and development.

For more such content

Click here